← Back
$INDV All transactions

Indivior Pharmaceuticals, Inc.

M

$ Value

Shares

6,302

Price

Filed

Mar 17

Insider

Name

Preblick Ryan

Title

Chief Financial Officer

CIK

0002014866

Roles

Officer

Transaction Details

Transaction Date

2026-03-14

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

323,594

Footnotes

Restricted stock units (RSUs) convert into shares of the Issuer's common stock on a one-for-one basis. | Shares used to satisfy tax withholding obligations associated with the vesting of RSUs on March 14, 2026. | On March 14, 2024, the reporting person was granted 6,302 RSUs in accordance with the Indivior Group Deferred Bonus Plan 2018. Those RSUs vested in a single installment on March 14, 2026.

Filing Info

Accession No.

0002014866-26-000008

Form Type

4

Issuer CIK

0001625297

Preblick Ryan's History

Date Ticker Type Value
2026-03-14 INDV M
2026-03-14 INDV F $88K
2026-03-14 INDV M
2026-03-03 INDV F $2.8M
2026-03-03 INDV M
2026-03-03 INDV M
2026-02-10 INDV A $0
2026-02-09 INDV A $0

Other Insiders at INDV (90d)

Insider Bought Sold Last
Kingsley Stuart A $30K 2026-03-06
Ryan Barbara $1K 2026-03-13
NINIVAGGI DANIEL A 2026-01-26
Ciaffoni Joseph
Chief Executive Officer
2026-02-10
Burris Jeffrey W
Chief Legal Officer
2026-03-03
Stejbach Mark 2026-01-26
Thompson Juliet 2026-01-26
Barry Patrick A
Chief Commercial Officer
2026-02-10
Wheadon David E. 2026-01-26
Anderson Woodrow D
Chief Accounting Officer
2026-03-03
Heidbreder Christian
Chief Scientific Officer
2026-03-03
Preblick Ryan
Chief Financial Officer
2026-03-14
Humphreys Keith 2026-01-26